News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Científico analizando muestras de plantas en un laboratorio
AseBio welcomes progress in the european reform of genetically modified microorganism legislation and calls for maintaining regulatory ambition
Healthcare · Agrifood · Food & feed · Agriculture
AseBio believes the reform is moving in the right direction, while calling for regulatory ambition…
Imagen Tabla Genesis Biomed
What do the Catalan healthcare startups that raised the most funding in 2025 have in common?
Healthcare · Financing · Communication
The largest funding rounds of 2025 were concentrated in companies that combine an unmet need, solid…
Partners - GENESIS Biomed
Proyecto FRACTAL
Natac Biotech receives €1.4 Million from the Spanish Ministry of Industry for the FRACTAL Project
Financing
The funding will support the development of a new generation of high-value natural ingredients…
Partners - Natac Group
Oryzon
ORYZON announces U.S. patent grant for vafidemstat in borderline personality disorder (BPD)
Healthcare · Rare diseases · Innovative drugs
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD.
Partners - Oryzon Genomics
Científico mostrando una vacuna junto con animales
Zoonotic diseases highlight the need to strengthen prevention and the One Health approach to future health threats
Healthcare · Climate change · Animal health · Industrial biotechnology
On World Zoonoses Day, we spoke with HIPRA, one of the European biotechnology companies most…
AseBio - HIPRA HUMAN HEALTH S.L.U.
Talent Day de BIOSPAIN 2026
Join the BIOSPAIN 2026 Talent Day: Connecting Biotech Companies with Specialized Talent
International · BioSpain · Talento
The congress, which will take place in Bilbao from 29 September to 1 October, will…
oryzon
ORYZON raises €12 million and signs a financing agreement with COFIDES to strengthen its balance sheet and accelerate its clinical programs
Healthcare · Innovative drugs · Financing
Priced at €2.70 per share, representing a 14.15% discount on the five day VWAP and a 12.68%…
Partners - Oryzon Genomics
Tonia Vilaplan, CEO de Viva in Vitro
Immunological information: the new strategic infrastructure of personalised medicine
Healthcare · Personalized medicine
Toni Vilaplana, CEO of Viva in Vitro Diagnostics.
AseBio - VIVA IN VITRO
Laboratorio de seguridad química
Biobide's DNT assay validated by NIH and US-EPA
Healthcare · Drug discovery · International
A study led by NIEHS/NIH, with participation from Biobide, the US-EPA, the University of Konstanz,…
Partners - Biotechnology Assets